SEC Form 4 · accession 0001123292-18-001005
Innovation Pharmaceuticals Inc. · IPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Peter Bertolino
Officer — President and CMO
Period of report
Oct 12, 2018
Accepted (ET)
Oct 15, 2018 · 6:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355250
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Oct 12, 2018 | F | 218,946 | $0.40 | D | 2,480,927 | D |
Table II — derivative securities
No Table II lines on this filing.